Dog /

Breed profile · FDA CVM July 2026 extract

Lhasa Apso adverse-event record

Adverse-event filings for Lhasa Apso (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

Verify with FDA CVM →
#58 of 510
by report volume (all breeds)
3,196
FDA CVM reports on file
3.7%
death-coded share of reports
#196 of 275
by death-coded share (≥50 reports)

How the 3,196 reports break down

By recorded gender -- every report on file for Lhasa Apso, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 151 113.25 75.5 37.75 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Lhasa Apso drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Lhasa Apso ranks #58 of 510 by total reports (3,196) and #196 of 275 by death-coded share (3.7%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#58
This breed, reports of 510
#196
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Lhasa Apso has 3,196 reports now versus 3,178 in that prior snapshot: 18 more (0.6%).

Report change
+18
Death-coded reports
+1
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Lhasa Apso changes

Total Reports

3,196

High report volume

Deaths Reported

118

of 3,196 reports

Death-coded share of reports

3.7%

Below-median death-coded share

Avg Age at Report

7.5 yr

8.3 kg avg weight

Breed Safety Scorecard

B+ (77/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate B
3.7%

Share of reports coded as a fatality

Euthanasia rate B
1.7%

Share of reports resulting in euthanasia

Full recovery rate A
37.2%

Share of reports coded "Recovered/Normal"

5-year trend B+
-17%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Lhasa Apso death-coded reports 3.7%
Cross-breed median

3.7% of 3,196 lhasa apso reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Lhasa Apso's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

4% 29th percentile Higher share than 29% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Lhasa Apso 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Lhasa Apso among report-volume vs. death-rate peers

Every breed shown has at least 50 filed reports. Volume reflects how often a breed is reported, not how common it is; death rate is the share of a breed's own reports coded as a death outcome.

Source: FDA openFDA Animal & Veterinary Adverse Events database 2×2 strategic matrix plotting 30 entities by Total Reports (X) and Death Rate (%) (Y), with a crosshair dividing the plot into four quadrants. High volume, high death rateLow volume, high death rateHigh volume, low death rateLow volume, low death rate 020,00040,00060,00080,000100,000 0%5%10%15% Total Reports Death Rate (%) Lhasa Apso vs. all breeds, report volume and death-coded share Retriever - Labrador-93675, 3.7%Crossbred Canine/dog-70591, 3.2%Domestic Shorthair-65226, 7.2%Dog (unknown)-48820, 8.8%Retriever - Golden-35980, 3.7%Shepherd Dog - German-32220, 4.4%Chihuahua-31521, 4.2%Terrier - Yorkshire-24924, 3.7%Shih Tzu-24405, 3.6%Boxer (German Boxer)-19405, 4.4%Beagle-17970, 3.6%Pit Bull-17865, 3.1%Shepherd Dog - Australian-16274, 3.7%Terrier (unspecified)-14058, 3.1%Maltese-13940, 3.2%Dachshund (unspecified)-13512, 4.6%Cat (unknown)-13248, 9.3%Terrier - Jack Russell-10423, 3.7%Collie - Border-10130, 4.3%Siberian Husky-9811, 4.5%Domestic Longhair-9615, 7%Pug-9224, 5.2%Spitz - German Pomeranian-9086, 4.9%Terrier - Bull - American Pit-8769, 4.7%Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog)-7871, 3.6%Terrier - Boston-7737, 4.5%Spaniel - Cocker American-7640, 4%Domestic (unspecified)-7576, 13.4%Poodle (unspecified)-7534, 3.4%Schnauzer - Miniature-7513, 4.4%
Source: FDA openFDA Animal & Veterinary Adverse Events database
Average weight at time of report: 8.3 kg (18.3 lbs)

Top Reported Reactions

Vomiting 717
Emesis 438
Lethargy (see also Central nervous system depression in 'Neurological') 315
Lack of efficacy (ectoparasite) - flea 270
Diarrhoea 250
Lack of efficacy - NOS 184
Anorexia 149
Seizure NOS 111
Pruritus 101
Lack of efficacy (endoparasite) - hookworm 100
Lack of efficacy (tick) 79
Other abnormal test result NOS 77
Decreased appetite 77
Behavioural disorder NOS 73
Lack of efficacy (flea) 73

Most Referenced Drugs

Milbemycin Oxime + Spinosad 659
Spinosad 364
Oclacitinib Maleate 183
Afoxolaner 160
Ivermectin + Pyrantel As Pamoate Salt 156
Fluralaner Chew Tablets 147
Afoxolaner 28.3 Mg Chewable Tablets 131
Trilostane 124
Moxidectin 82
Pyrantel Pamoate;Sarolaner 78
Selamectin 68
Carprofen 66
Sarolaner 61
Cyclosporine A 56
Fluralaner 13.64% 12-Week Chew 56

Outcome Breakdown

Recovered/Normal
1,188 (40.8%)
Outcome Unknown
875 (30.1%)
Ongoing
594 (20.4%)
Recovered with Sequela
135 (4.6%)
Died
63 (2.2%)
Euthanized
55 (1.9%)

Gender Distribution

Male 1,709 (53.5%)
Female 1,423 (44.5%)
Unknown 56 (1.8%)
Mixed 8 (0.3%)

Reports by Year

Year Reports Trend
2010 161
2011 227
2012 344
2013 326
2014 281
2015 316
2016 316
2017 295
2018 164
2019 151
2020 126
2021 103
2022 94
2023 98
2024 98
2025 86
2026 10

Lhasa Apso: low death-coded share in the FDA CVM extract

Signature read: 3,196 reports place Lhasa Apso in the upper third of breed filing volume (#58 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Lhasa Apso sits at #58 of 510 by report volume among all breeds and #52 of 298 among dog breeds, with 3,196 reports and 118 (3.7%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #196 of 275. Mean age at report: 7.5 years, average weight 8.3 kg (18.3 lbs).

Top reported signs: Vomiting (717), Emesis (438), Lethargy (see also Central nervous system depression in 'Neurological') (315). Most-referenced drug: Milbemycin Oxime + Spinosad (659 reports), followed by Spinosad (364) and Oclacitinib Maleate (183).

Outcome coding on 2,910 status-recorded reports is dominated by Recovered/Normal (40.8%). Annual submissions ranged 10-2,026 across 17 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Spaniel (unspecified)
3,209 reports · 4.8% death-coded
Collie (unspecified)
3,131 reports · 4.8% death-coded
Terrier - Rat
3,078 reports · 4.3% death-coded
Mountain Dog - Bernese
3,012 reports · 4.2% death-coded
Mastiff
2,950 reports · 6.2% death-coded
Retriever (unspecified)
3,492 reports · 1.9% death-coded

Nationwide breeds with similar profiles

High-volume peer sets for Lhasa Apso drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (3.7% death-coded here).

British cat 3.8% · Cat American Curl Shorthair 3.5% · Cat Siberian 4.2% · Cat Oriental 3.1% · Cat

Similar average weight

Nearest other-species breeds by reported average weight (8.3 kg here).

Nigerian Dwarf 7.5 kg · Goat Primate (other) 10.1 kg · Primate Maine Coon 6.1 kg · Cat Norwegian Forest 5.8 kg · Cat

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Lhasa Apso? ▼
There are 3,196 adverse event reports involving Lhasa Apso in the FDA database, of which 118 were death-coded (3.7% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Lhasa Apso ranks #58 of 510 by report volume among all breeds PlainBreed indexes (#52 of 298 among dog breeds).
Where does Lhasa Apso sit among other breeds in PlainBreed's corpus? ▼
According to FDA CVM report volume, Lhasa Apso is #58 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #52 of 298. Among breeds with at least 50 reports, its death-coded share ranks #196 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Lhasa Apso? ▼
The most commonly reported adverse reactions for Lhasa Apso are Vomiting (717 reports), Emesis (438 reports), Lethargy (see also Central nervous system depression in 'Neurological') (315 reports), Lack of efficacy (ectoparasite) - flea (270 reports), Diarrhoea (250 reports).
What drugs are most frequently associated with Lhasa Apso adverse events? ▼
The drugs most frequently referenced in Lhasa Apso adverse event reports are Milbemycin Oxime + Spinosad (659 reports), Spinosad (364 reports), Oclacitinib Maleate (183 reports), Afoxolaner (160 reports), Ivermectin + Pyrantel As Pamoate Salt (156 reports).
What is the average age of Lhasa Apso in adverse event reports? ▼
The average age of Lhasa Apso at the time of adverse event reports is 7.5 years, with an average weight of 8.3 kg (18.3 lbs).

Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Lhasa Apso (Dog), extract as of July 2026 extract. 3,196 reports · 118 death-coded (3.7% of reports, not a mortality rate) · #58 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →